Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-03-10 | NOVAVAX INC | Kelly James Patrick
(EVP, CFO and Treasurer) |
F | Common Stock | D | 2226 | $5.45 - $5.45 | $12,131 |
2024-03-10 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
F | Common Stock | D | 2597 | $5.45 - $5.45 | $14,153 |
2024-03-10 | NOVAVAX INC | Trizzino John
(President and COO) |
F | Common Stock | D | 2226 | $5.45 - $5.45 | $12,131 |
2024-03-07 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
F | Common Stock | D | 9392 | $5.61 - $5.61 | $52,689 |
2024-03-07 | NOVAVAX INC | Trizzino John
(EVP, CCO and CBO) |
F | Common Stock | D | 13955 | $5.61 - $5.61 | $78,287 |
2024-03-07 | NOVAVAX INC | Kelly James Patrick
(EVP, CFO and Treasurer) |
F | Common Stock | D | 5905 | $5.61 - $5.61 | $33,127 |
2024-03-01 | NOVAVAX INC | O'Hara Elaine
(EVP, Chief Strategy Officer) |
M | Common Stock | A | 19600 | $5.39 - $5.39 | $105,644 |
2024-03-01 | NOVAVAX INC | O'Hara Elaine
(EVP, Chief Strategy Officer) |
F | Common Stock | D | 5375 | $5.39 - $5.39 | $28,971 |
2024-01-23 | NOVAVAX INC | Jacobs John C
(President and CEO) |
F | Common Stock | D | 40093 | $4.26 - $4.26 | $170,796 |
2023-11-05 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
M | Common Stock | A | 1400 | $7.06 - $7.06 | $9,884 |
2023-11-05 | NOVAVAX INC | Dubovsky Filip
(President, R&D) |
F | Common Stock | D | 677 | $7.06 - $7.06 | $4,779 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |